Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 338,157	$ 1,123,843
Short-term investments	100,763	104,870
Accounts receivable, net	248,055	241,931
Prepaid expenses	18,896	16,898
Income taxes receivable	29,055	0
Other current assets	17,387	61,806
Total current assets	752,313	1,549,348
Property and equipment, net	68,481	76,191
Goodwill	1,487,105	1,477,968
Intangible assets, net	19,989	26,642
Operating and finance lease right-of-use assets	56,508	55,972
Deferred income tax assets	56,329	54,472
Other assets	114,405	107,355
Total assets	2,555,130	3,347,948
Current liabilities:
Accounts payable and accrued expenses	329,918	423,183
Current portion of finance lease liabilities	2,339	2,219
Current portion of operating lease liabilities	18,848	18,933
Total current liabilities	351,105	444,335
Long-term debt and finance lease liabilities, net	996,643	1,742,586
Long-term operating lease liabilities	39,977	40,970
Long-term professional liabilities	267,319	265,274
Deferred income tax liabilities	48,428	61,746
Other liabilities	42,534	45,320
Total liabilities	1,746,006	2,600,231
Commitments and contingencies
Shareholders' equity:
Preferred stock; $.01 par value; 1,000 shares authorized; none issued	0	0
Common stock; $.01 par value; 200,000 shares authorized; 86337 and 85,593 shares issued and outstanding, respectively	863	856
Additional paid-in capital	1,039,231	1,029,453
Accumulated other comprehensive income	2,513	3,530
Retained deficit	(233,701)	(286,354)
Total Mednax, Inc. shareholders' equity	808,906	747,485
Noncontrolling interest	218	232
Total equity	809,124	747,717
Total liabilities and equity	$ 2,555,130	$ 3,347,948